ON Semiconductor stock price target raised to $51 at Truist Securities

Investing.comTuesday, November 4, 2025 at 3:24:50 PM
ON Semiconductor stock price target raised to $51 at Truist Securities
ON Semiconductor has received a boost as Truist Securities has raised its stock price target to $51. This adjustment reflects confidence in the company's growth potential and market position, which is significant for investors looking for promising opportunities in the semiconductor industry.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
ON Semiconductor stock price target lowered to $64 at CFRA on AI push
NeutralFinancial Markets
CFRA has lowered its stock price target for ON Semiconductor to $64, reflecting the company's ongoing push into artificial intelligence. This adjustment highlights the market's cautious stance on the tech sector's performance amid evolving AI trends. Investors should keep an eye on how ON Semiconductor adapts to these changes, as it could impact their future growth and stock performance.
Truist Securities downgrades Denny’s stock to Hold after acquisition news
NegativeFinancial Markets
Truist Securities has downgraded Denny's stock to a 'Hold' rating following news of an acquisition. This decision reflects concerns about the potential impacts of the acquisition on Denny's future performance. Investors should pay attention to how this change might affect the company's stock value and overall market position.
Earnings call transcript: ON Semiconductor Q3 2025 shows EPS beat, stock dips
NeutralFinancial Markets
ON Semiconductor's Q3 2025 earnings call revealed that the company beat earnings per share (EPS) expectations, which is typically a positive sign for investors. However, despite this good news, the stock experienced a dip, raising questions about market reactions and future performance. Understanding these dynamics is crucial for investors as they navigate the complexities of the semiconductor industry.
Truist Securities reiterates Buy rating on Edgewise Therapeutics stock
PositiveFinancial Markets
Truist Securities has reaffirmed its Buy rating on Edgewise Therapeutics stock, signaling confidence in the company's potential for growth and success in the market. This endorsement is significant as it reflects the analysts' belief in Edgewise's innovative approach and future prospects, which could attract more investors and boost the stock's performance.
Truist Securities raises LendingTree stock price target to $72 on insurance growth
PositiveFinancial Markets
Truist Securities has raised its price target for LendingTree's stock to $72, citing significant growth in the insurance sector. This adjustment reflects confidence in LendingTree's ability to expand its services and enhance profitability, which is great news for investors. As the company continues to innovate and capture market share, this positive outlook could lead to increased investor interest and potentially higher stock performance.
ON Semiconductor posts strong Q3 amid AI demand
PositiveFinancial Markets
ON Semiconductor has reported impressive earnings for the third quarter, driven by a surge in demand for AI technologies. This strong performance highlights the company's strategic positioning in the semiconductor market, particularly as industries increasingly rely on AI solutions. The results not only reflect ON Semiconductor's growth but also underscore the broader trend of rising investments in AI, making it a key player in the tech landscape.
Latest from Financial Markets
Private-Credit Earnings Ease Investor Concern Over Asset Class’s Health
PositiveFinancial Markets
Apollo CEO Marc Rowan has reassured investors by addressing concerns regarding the health of the private-credit asset class, easing worries and highlighting the stability of the sector.
Private-Credit Earnings Ease Investor Concern Over Asset Class’s Health
PositiveFinancial Markets
Apollo CEO Marc Rowan has reassured investors by addressing concerns regarding the health of the private-credit asset class, easing worries and highlighting the sector's resilience.
Aviat Networks Q1 FY2026 slides: Revenue jumps 21.4%, exceeding expectations
PositiveFinancial Markets
Aviat Networks reported a remarkable 21.4% increase in revenue for Q1 FY2026, surpassing market expectations. This growth highlights the company's strong performance and positive outlook in the telecommunications sector.
Stoke Therapeutics Q3 2025 presentation: strong revenue growth amid clinical progress
PositiveFinancial Markets
Stoke Therapeutics recently presented its Q3 2025 results, showcasing impressive revenue growth alongside significant advancements in its clinical programs. The company's progress highlights its commitment to developing innovative therapies, making it a key player in the biotechnology sector.
Amgen Q3 2025 slides: Revenue up 12%, guidance raised on strong product performance
PositiveFinancial Markets
Amgen has reported a 12% increase in revenue for Q3 2025, prompting the company to raise its guidance due to strong product performance. This positive trend highlights the effectiveness of their strategies and the growing demand for their offerings.
Corsair Q3 2025 slides show strong growth amid missed earnings forecasts
NeutralFinancial Markets
Corsair's Q3 2025 slides indicate a strong growth trajectory, despite missing earnings forecasts. The company is navigating challenges while showcasing resilience in its performance.